Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection

INTRODUCTION: Many with post-acute SARS-CoV-2 (PASC) have persistent symptoms impacting physical and cognitive function, decreased health and health-related life quality. Monoclonal antibody (mAb) treatment was available to acutely infected patients which might improve these outcomes. PURPOSE: To co...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Jillian Kallman, Gerber, Lynn H, Stepanova, Maria, de Avila, Leyla, Weinstein, Ali A, Pham, Huong, Nader, Fatema, Afendy, Mariam, Terra, Kathy, Austin, Patrick, Keo, Wisna’odom, Racila, Andrei, Estep, James Michael, Gerber, Suzannah, Verma, Manisha, Golabi, Pegah, Lam, Brian P, Younossi, Zobair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145429/
https://www.ncbi.nlm.nih.gov/pubmed/37123886
http://dx.doi.org/10.2147/IJGM.S406571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145429/
https://www.ncbi.nlm.nih.gov/pubmed/37123886
http://dx.doi.org/10.2147/IJGM.S406571

Ejemplares similares